Arbutus Biopharma Corp (ABUS)

Feb 20, 2025

Will Moderna Stock Drop to $25? 1 Wall Street Analyst Thinks So. - The Motley Fool

Feb 20, 2025

Feb 20, 2025

Arbutus Biopharma's CFO David Hastings sells shares worth $72,826 - MSN

Feb 20, 2025

Feb 12, 2025

The Hidden Gem in Nasdaq’s Under $5 Club: Is Arbutus Biopharma the Next Big Thing? - Jomfruland.net

Feb 12, 2025

Feb 12, 2025

Is Arbutus Biopharma Corp. (ABUS) the Best Nasdaq Stock Under $5 to Buy? - Insider Monkey

Feb 12, 2025

Feb 11, 2025

Ebola Virus Vaccine Market May See a Big Move| Arbutus Biopharma, BioCryst Pharmaceuticals - openPR

Feb 11, 2025

Feb 08, 2025

SG Americas Securities LLC Purchases 16,250 Shares of Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Feb 08, 2025

Feb 06, 2025

Arbutus Biopharma Corp (ABUS) Stock: A Look at the Monthly Trend - The News Heater

Feb 06, 2025

Feb 05, 2025

Jefferies analysts upgrades a Buy rating for Arbutus Biopharma Corp (ABUS) - Knox Daily

Feb 05, 2025

Feb 05, 2025

Arbutus Biopharma Executives Sell Shares to Cover Tax Obligations - TradingView

Feb 05, 2025

Feb 04, 2025

Arbutus Biopharma Corp (ABUS) expanding its growth trajectory ahead - SETE News

Feb 04, 2025

Feb 03, 2025

Morgan Stanley Reduces Stake in Arbutus Biopharma Corp - GuruFocus.com

Feb 03, 2025

Jan 30, 2025

JPMorgan Chase & Co. Increases Stock Position in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Jan 30, 2025

Jan 27, 2025

Ballentine Partners LLC Acquires New Position in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Jan 27, 2025

Jan 27, 2025

Arbutus Biopharma Corp. to Host Earnings Call - ACCESS Newswire

Jan 27, 2025

Jan 22, 2025

Arbutus Biopharma (NASDAQ:ABUS) Receives “Buy” Rating from HC Wainwright - Defense World

Jan 22, 2025

Jan 21, 2025

Arbutus Biopharma (NASDAQ:ABUS) Receives "Buy" Rating from HC Wainwright - MarketBeat

Jan 21, 2025

Jan 17, 2025

Arbutus Biopharma Sets Sights on Advancing HBV Cure in 2025 - MyChesCo

Jan 17, 2025

Jan 16, 2025

Jim Cramer on Arbutus Biopharma Corporation (ABUS): ‘It Loses Money’ - Insider Monkey

Jan 16, 2025

Jan 15, 2025

Barclays PLC Purchases 223,995 Shares of Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Jan 15, 2025

Jan 13, 2025

Cramer's Lightning Round: Arbutus Biopharma is 'the ultimate spec' - MSN

Jan 13, 2025

Jan 13, 2025

Arbutus Provides 2025 Corporate and Financial Update - GlobeNewswire

Jan 13, 2025

Jan 13, 2025

Arbutus Biopharma Achieves 50% Cure Rate in Hepatitis Trial, Advances to Phase 2b with $123M Cash - StockTitan

Jan 13, 2025

Jan 11, 2025

Jane Street Group LLC Has $258,000 Holdings in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Jan 11, 2025

Jan 08, 2025

Principal Financial Group Inc. Sells 12,352 Shares of Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Jan 08, 2025

Jan 07, 2025

Arbutus Biopharma (NASDAQ:ABUS) Sees Large Volume IncreaseShould You Buy? - MarketBeat

Jan 07, 2025

Jan 07, 2025

Arbutus: Positive Imdusiran Data Leads To Phase 2B Development (NASDAQ:ABUS) - Seeking Alpha

Jan 07, 2025

Dec 31, 2024

Geode Capital Management LLC Buys 135,442 Shares of Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Dec 31, 2024

Dec 31, 2024

Barclays PLC Acquires 223,995 Shares of Arbutus Biopharma Co. (NASDAQ:ABUS) - MarketBeat

Dec 31, 2024

Dec 25, 2024

State Street Corp Increases Holdings in Arbutus Biopharma Co. (NASDAQ:ABUS) - MarketBeat

Dec 25, 2024

Dec 25, 2024

State Street Corp Purchases 1,472,652 Shares of Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Dec 25, 2024

Dec 22, 2024

Arbutus Biopharma Co. (NASDAQ:ABUS) Position Boosted by XTX Topco Ltd - Defense World

Dec 22, 2024

Dec 20, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Takes Position in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Dec 20, 2024

Dec 20, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Invests $754,000 in Arbutus Biopharma Co. (NASDAQ:ABUS) - MarketBeat

Dec 20, 2024

Dec 16, 2024

Arbutus Biopharma's SWOT analysis: hepatitis B focus drives stock potential - Investing.com

Dec 16, 2024

Dec 16, 2024

Arbutus Biopharma (NASDAQ:ABUS) Shares Gap DownHere's Why - MarketBeat

Dec 16, 2024

Dec 14, 2024

Charles Schwab Investment Management Inc. Grows Stock Holdings in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Dec 14, 2024

Dec 14, 2024

Charles Schwab Investment Management Inc. Purchases 831,663 Shares of Arbutus Biopharma Co. (NASDAQ:ABUS) - MarketBeat

Dec 14, 2024

Dec 08, 2024

Large Shareholder Urges Warminster-based Arbutus to Seek Partners Instead of Selling More Stock - MSN

Dec 08, 2024

Dec 08, 2024

Intech Investment Management LLC Takes Position in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Dec 08, 2024

Dec 06, 2024

Here’s Why Arbutus (ABUS) Surged in Q3 - Yahoo Finance

Dec 06, 2024

Dec 04, 2024

Arbutus Biopharma's SWOT analysis: focus on CHB treatment drives stock outlook - Investing.com

Dec 04, 2024

Dec 03, 2024

Whitefort Capital Sends Letter to Arbutus Biopharma Board of Directors - The Bakersfield Californian

Dec 03, 2024

Dec 03, 2024

Arbutus Biopharma's HBV Trial Hits 50% Cure Rate; Major Investor Urges Strategic Partnership - StockTitan

Dec 03, 2024

Dec 02, 2024

Arbutus Biopharma Co. (NASDAQ:ABUS) Short Interest Update - MarketBeat

Dec 02, 2024

Dec 01, 2024

Arbutus Biopharma (STU:I9DN) 9-Day RSI : 39.19 (As of Dec. 01, 2024) - GuruFocus.com

Dec 01, 2024

Nov 27, 2024

Principal Financial Group Inc. Reduces Holdings in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Nov 27, 2024

Nov 26, 2024

Arbutus to Participate in H.C Wainwright @ Home Virtual Fireside Chat - Yahoo Finance

Nov 26, 2024